Mettler-Toledo stock falls after Redburn issues sell rating and sets lower target

Mettler-Toledo International stock (ISIN US5926881054) is trading below recent highs after a fresh sell recommendation and lower price target from Redburn, even as consensus forecasts still imply earnings growth and a premium valuation as of September 2, 2026.

Redburn downgrade puts pressure on the shares

According to a report summarized by Zonebourse with MT Newswires on September 2, 2026, Rothschild and Co Redburn has turned pessimistic on Mettler-Toledo International and now recommends selling the stock.

The same overview shows the last closing price for Mettler-Toledo at 1,375.96 USD on the New York Stock Exchange, with a five day variation of minus 2.08 percent and a year to date change of minus 1.31 percent as of the September 1, 2026 close.

Consensus view and valuation remain relatively constructive

Despite the new sell recommendation, the broader analyst consensus compiled by Zonebourse still describes the stock as an accumulate idea, with 13 analysts covering Mettler-Toledo and an average target price of 1,472.75 USD compared with the 1,375.96 USD last close, implying upside of 7.03 percent.

RBC Capital Markets recently highlighted what it sees as strong pricing power at Mettler-Toledo in the analytical instruments sector and set a price target of 1,515 USD, a level that sits above the current average target and around 10.1 percent above the last closing price of 1,375.96 USD as of September 1, 2026, according to a note reported by Finimize.

Market data from MarketBeat as of September 1, 2026 shows Mettler-Toledo trading at about 1,371.22 USD intraday, within a 52 week range of 1,023.05 USD to 1,525.17 USD and giving the company a market capitalization of approximately 27.48 billion USD.

Recent earnings and profitability support the premium rating

In its most recent reported quarter, which ended June 30, 2026 and was discussed on the July 31, 2026 earnings call, Mettler-Toledo delivered earnings per share of 11.46 USD, beating a consensus estimate of 10.78 USD by 0.68 USD, while revenue grew 4.5 percent year on year, according to the earnings data cited on MarketBeat.

On a trailing twelve month basis, MarketBeat reports earnings per share of 44.43 USD and net income of 869.19 million USD, corresponding to a net margin of 21.91 percent and a pretax margin of 26.55 percent, metrics that help explain why investors are willing to assign the shares a price to earnings ratio of 30.87 as of early September 2026.

The same data set indicates annual sales of approximately 4.03 billion USD and cash flow of 48.66 USD per share, implying a price to sales ratio of 6.82 and a price to cash flow ratio of 28.18, with a forward price to earnings multiple around 28.96 based on projected earnings of 52.27 USD per share for the coming year.

Business mix and a representative product line

Company profile information compiled by Zonebourse shows that Mettler-Toledo generates about 55.7 percent of its revenue from laboratory research and development solutions, including analytical balances, precision balances, microbalances, titration systems, pH meters, density meters, refractometers, thermal analysis instruments and automated reactors.

Industrial applications account for roughly 39.2 percent of revenue through industrial scales, process analytics systems and industrial inspection and control equipment, while the remaining 5.1 percent comes from food retail solutions such as point of sale scales and packaging and labeling systems.

A representative product for many investors and customers is the company laboratory balances family, which includes high precision analytical balances used in pharmaceutical and biotech laboratories where accurate weighing down to microgram levels is crucial for compliant formulation and research workflows.

Stock price context and investor perspective

Looking at the stock price in context, MarketBeat data as of September 1, 2026 indicates that Mettler-Toledo shares have traded between 1,023.05 USD and 1,525.17 USD over the past 52 weeks, with the recent level around 1,371 to 1,376 USD placing the stock closer to the upper half of that range.

For investors, the key question in the current environment is whether the combination of solid profitability, mid single digit revenue growth and forecast earnings expansion of about 10.39 percent over the coming year, as cited by MarketBeat, is enough to justify a price to earnings ratio near 31 when some analysts now argue the stock is fully valued or even overvalued.